Person

Karthik Kuppusamy

SVP, Clinical Solutions, Quest Diagnostics

Current S&P 500 boards
0
Current roles
1
Open-market buys
$0
Open-market sales
$5.2M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Jun 4, 2026DGXSale8,147$200.00$1.6M
Mar 4, 2026DGXSale2,628$204.86$538K
Jul 31, 2025DGXSale2,210$170.00$376K
Jul 30, 2025DGXSale3,045$167.40$510K
Jul 30, 2025DGXSale5,224$167.40$874K
Apr 2, 2025DGXSale2,555$170.00$434K
Oct 28, 2024DGXSale1,775$156.92$279K
Aug 28, 2024DGXSale1,990$153.26$305K
Apr 29, 2024DGXSale1,760$140.00$246K

SEC reporting-owner ID (CIK) 1955217 · all filings on EDGAR